title: Factor Xa inhibitors: next-generation antithrombotic agents.
authors.affiliation: Research and Development, Bristol-Myers Squibb Company, PO Box 5400, Princeton, New Jersey 08543, USA.
authors.forename: Donald J P
authors.initials: DJ
authors.lastname: Pinto
authors.forename: Joanne M
authors.initials: JM
authors.lastname: Smallheer
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Cheney
authors.forename: Robert M
authors.initials: RM
authors.lastname: Knabb
authors.forename: Ruth R
authors.initials: RR
authors.lastname: Wexler
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D001682:Biological Availability; D002986:Clinical Trials as Topic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D065427:Factor Xa Inhibitors; D006487:Hemostasis; D006801:Humans; D008958:Models, Molecular; D011487:Protein Conformation; D013329:Structure-Activity Relationship; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors